Related Experiment Video
Updated: Jun 9, 2025

09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
296
Supramolecular Assemblies via Host-Guest Interactions for Tumor Immunotherapy
Meng Zhao1, Qinghao Zhou1, Zhishen Ge1
1School of Chemistry, Xi'an Key Laboratory of Sustainable Polymer Materials, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, China.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|October 24, 2024
Summary
Supramolecular assemblies utilizing host-guest interactions offer advanced cancer immunotherapy delivery systems. These materials enhance drug encapsulation and targeted release, boosting antitumor immune responses.
Area of Science:
- Biomedical Engineering
- Materials Science
- Immunology
Background:
- Cancer immunotherapy shows promise, offering advantages over traditional treatments.
- Supramolecular assemblies based on host-guest interactions are explored for drug delivery in cancer immunotherapy.
- These assemblies offer unique features for drug encapsulation, targeting, and release.
Purpose of the Study:
- To review research on supramolecular assemblies via host-guest interactions for tumor immunotherapy.
- To discuss various drug delivery systems, their construction, and drug delivery capabilities.
- To outline advantages, disadvantages, and future perspectives in this field.
Main Methods:
- Review of scientific literature on supramolecular assemblies and cancer immunotherapy.
- Analysis of host-guest interactions in the design of drug delivery systems.
- Discussion of material types including hydrogels, liposomes, and polymeric nanoparticles.
Main Results:
- Supramolecular assemblies enable efficient drug encapsulation and targeted delivery for cancer immunotherapy.
- These systems can activate antitumor immune responses, particularly with combination strategies.
- Various supramolecular materials demonstrate unique features beneficial for therapeutic applications.
Conclusions:
- Supramolecular assemblies are a promising platform for advancing cancer immunotherapy.
- Host-guest chemistry provides a versatile approach for designing sophisticated drug delivery systems.
- Further development holds potential for improved cancer treatment outcomes.
Related Concept Videos
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

